Skip to main content
TipRanks
Go Ultimate75% OFF

Shanghai Pharmaceuticals Holding Co (S1R) Income Statement

1 Followers

Shanghai Pharmaceuticals Holding Co Income Statement

Last quarter (Q3 2026), Shanghai Pharmaceuticals Holding Co's total revenue was ¥75.48B, an increase of 2.76% from the same quarter last year. In Q3, Shanghai Pharmaceuticals Holding Co's net income was ¥1.08B. See Shanghai Pharmaceuticals Holding Co’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Mar 24Dec 22Dec 21
¥ 283.58B¥ 275.25B¥ 260.30B¥ 231.98B¥ 215.82B
¥ 30.42B¥ 30.63B¥ 30.93B¥ 30.49B¥ 28.54B
¥ 20.47B¥ 22.49B¥ 23.26B¥ 21.71B¥ 20.62B
Depreciation and Amortization¥ 2.86B¥ 2.42B¥ 2.19B¥ 2.22B¥ 2.14B
¥ 14.37B¥ 12.06B¥ 10.90B¥ 12.44B¥ 10.55B
¥ 9.94B¥ 8.14B¥ 7.67B¥ 9.01B¥ 8.21B
¥ -122.28M¥ -120.71M¥ -612.94M¥ -206.30M¥ -61.67M
¥ 9.82B¥ 8.02B¥ 7.05B¥ 8.81B¥ 8.14B
¥ 5.72B¥ 4.55B¥ 3.77B¥ 5.62B¥ 5.09B
Per Share Metrics
Basic EPS¥ 1.54¥ 1.23¥ 1.02¥ 1.61¥ 1.79
Diluted EPS¥ 1.54¥ 1.23¥ 1.02¥ 1.61¥ 1.79
Weighted Average Shares Outstanding3.71B3.70B3.70B3.48B2.84B
Weighted Average Shares Outstanding (Diluted)3.71B3.70B3.70B3.49B2.85B

Currency in CNY

Shanghai Pharmaceuticals Holding Co Earnings and Revenue History

0100B200B300B1.2 %1.8 %2.4 %3 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin